Keywords: micrologix, licenses, hepatitis, drug, canada, obtained, worldwide

Micrologix licenses hepatitis C drug

Article | 09 February 2004

Print This

Canada's Micrologix has obtained worldwide rights to the antiviral celgosivir from UK-based Virogen. The agent has undergone Phase I/II ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in